ISSN 1016-5169 | E-ISSN 1308-4488
Percutaneous Closure of Left Atrial Appendage: A New Option for the Prevention of Thromboembolic Stroke [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2011; 39(8): 668-674 | DOI: 10.5543/tkda.2011.01727

Percutaneous Closure of Left Atrial Appendage: A New Option for the Prevention of Thromboembolic Stroke

Ali Oto, Kudret Aytemir, Sercan Okutucu, Ergün Barış Kaya, Levent Şahiner, Cingiz Sabanov, Banu Evranos
Department Of Cardiology, Hacettepe University, Ankara, Turkey


OBJECTIVES
Percutaneous left atrial appendage (LAA) closure is an important therapeutic option for prevention of thromboembolic stroke in patients with atrial fibrillation (AF), especially when contraindications exist for oral anticoagulation. We aimed to evaluate our short-term results of LAA closure (initial experience) using the WATCHMAN LAA system.

STUDY DESIGN
Eleven patients (8 men, 3 women; mean age 68.4±7.0 years) with nonvalvular AF, a high risk for cardioembolic stroke (mean CHADS2 score 2.6±1.2, mean CHA2DS2-VASc score 4.0±1.5), and contraindications to oral anticoagulation underwent percutaneous LAA closure using the WATCHMAN LAA system. All the procedures were performed under general anesthesia and fluoroscopy and transesophageal echocardiography (TEE) guidance. The patients were evaluated clinically (at 45 days and 6 months) and by TEE (at 45 days).

RESULTS
The LAA was successfully occluded in all the patients (100%). The mean procedural and fluoroscopy times were 58.6±8.1 and 19.1±5.2 minutes, respectively. The mean diameter of the LAA ostium was measured as 20.4±3.8 mm by TEE. The mean device size was 24.6±3.8 mm. The mean hospital stay was 1.7±0.9 days. Follow-up TEE showed closure of all LAA orifices without device-related thrombus formation. Two patients (18.2%) had minimal peri-device leaks (<3 mm). None of the patients experienced major adverse events during a median follow-up of 90 days (interquartile range 60-185 days).

CONCLUSION
Our initial experience suggests that percutaneous LAA closure with the WATCHMAN LAA system is safe and feasible, with favorable short-term clinical outcomes.

Keywords: Atrial appendage, atrial fibrillation, echocardiography, transesophageal; prosthesis implantation/instrumentation; stroke/prevention & control

Corresponding Author: Sercan Okutucu, Türkiye
Manuscript Language: Turkish
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search

Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.